As the world marks international Heart Month, the Ted Rogers Centre for Heart Research today announces its first-ever $1 million innovation grants, awarded to world-first projects positioned to alleviate the massive burden of heart failure on patients, loved ones and health-care systems.
A deceased donor kidney has been preserved and kept healthy outside the body in a device that mimics the body’s physiological functions and successfully transplanted into a human, for the first time in North America.
The Princess Margaret Cancer Foundation would like to invite media to attend this year’s Taylor Cup Pond Hockey Championship.
With a transformational gift of $20 million to the Toronto Rehab Foundation, Walter and Maria Schroeder, along with their family, have established The Walter and Maria Schroeder Brain Institute.
A research team led by scientists at the Krembil Research Institute in Toronto has identified a new neuroprotective factor that has the potential to help people suffering from the common blinding disease glaucoma.
Breast cancer researchers have mapped early genetic alterations in normal-looking cells at various distances from primary tumours to show how changes along the lining of mammary ducts can lead to disease.
In a national first, researchers from the iDAPT labs at Toronto Rehabilitation Institute-University Health Network have launched DriverLab, an underground, state-of-the-art research simulator, designed to study the impact of our health on driving performance, with an aim to increase driver safety in healthy older adults and people living with injury or illness.
University Health Network (UHN) announced today that The Peter and Melanie Munk Charitable Foundation is increasing its support to the Peter Munk Cardiac Centre (PMCC) with a transformative gift of $100 million.
A task force consisting of researchers from around the world and led by a scientist at the Krembil Research Institute in Toronto has released a set of recommendations that advise against the use of brain imaging as a test for chronic pain.
The Ted Rogers Centre for Heart Research today announces that Dr. Raymond Kim is its newest scientific lead, guiding efforts at the country’s only clinic devoted to cardiac genomics.
A pilot study conducted by the Canadian Concussion Centre has shown that using a non-LCD screen for computer tasks may decrease the risk of exacerbating symptoms in sufferers of post-concussion syndrome (PCS).
The Krembil Neuroscience Centre’s Canadian Concussion Centre (CCC) announces that the analysis of the brain of former CFL player, Rick Klassen, showed signs of chronic traumatic encephalopathy (CTE) – a neurodegenerative brain disorder linked to multiple concussions.
Leukemia researchers led by Dr. John Dick have traced the origins of relapse in acute myeloid leukemia (AML) to rare therapy-resistant leukemia stem cells that are already present at diagnosis and before chemotherapy begins.
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids.
At the Annual General Meeting of Toronto’s University Health Network (UHN) on June 14, 2017, Mr. Brian Porter, President and Chief Executive Officer of Scotiabank, was elected Chair of the Board of Trustees of UHN.
In a Canadian first, a medical team has implanted a wireless device inside a heart failure patient, permitting clinicians to monitor the patient’s cardiovascular status – virtually and in real-time – and proactively adjust treatment to prevent costly, potentially unnecessary hospitalization.
A new, minimally invasive system which uses radiofrequency energy instead of open surgery to create access for patients needing hemodialysis, is reliable, with minimal complications, according to data published in the American Journal of Kidney Diseases.
A research team at the Krembil Neuroscience Centre in Toronto has published a paper that suggests seal oil has the potential to help promote nerve regeneration in patients with Type 1 diabetes.
Today, in the New England Journal of Medicine, the team from University Health Network in Toronto that developed the organization’s protocol for medical assistance in dying (MAiD) describes UHN’s approach and experience. This comes a year after Canada decriminalized medically assisted dying throughout the country.
The Princess Margaret Cancer Foundation welcomes Pizza Pizza as its new presenting sponsor for Scotiabank Road Hockey to Conquer Cancer through to 2019.
A new, first-of-its-kind app is now available to support clinicians with decisions on best practice rehabilitation strategies for patients with arm impairment due to stroke.
Ted Rogers Centre for Heart Research study is first to show TNF operating beyond immune system, Caution needed when administering anti-TNF medications
A multi-disciplinary medical team of interventional and structural cardiologists at the Peter Munk Cardiac Centre, University Health Network, has successfully completed a Canadian first – the implant of a TandemHeart circulatory support device designed to take over the function of a weak and damaged heart while allowing the heart’s pumping chamber or left ventricle time to recover – all without surgery.
An Ontario-led international clinical trial with 1,206 men with localized prostate cancer shows that compressing radiation treatments into four weeks from eight delivers similar outcomes.
Treating older patients who have malignant brain cancer with the chemotherapy drug temozolomide plus a short course of radiation therapy extends survival by two months compared to treating with radiation alone, show clinical trial results published today in the New England Journal of Medicine.
Ovarian cancer researchers have identified a protein biomarker expressed on the surface of tumour cells in high-grade serous ovarian cancer, the most common and lethal subtype of the disease.
Researchers at Toronto Western Hospital’s Canadian Concussion Centre (CCC) have discovered the presence of chronic traumatic encephalopathy (CTE) in the brain of a deceased patient with no known history of traumatic brain injury or concussion, the first known case of its kind.
Princess Margaret Cancer Centre scientists have discovered a distinct cell population in tumours that inhibits the body’s immune response to fight cancer.
The Peter Munk Cardiac Centre at Toronto General Hospital today announced the launch of the FIBrinogen REplenishment in Surgery (FIBRES) study in acquired fibrinogen deficiency.
In a bold and very challenging move, thoracic surgeons at Toronto General Hospital, University Health Network removed severely infected lungs from a dying mom, keeping her alive without lungs for six days, so that she could recover enough to receive a life-saving lung transplant.
The Princess Margaret Cancer Foundation is thrilled to announce the successful achievement of our Billion Dollar Challenge, in partnership with the Princess Margaret Cancer Centre at University Health Network.
Canadian and Australian prostate cancer researchers have discovered a key piece in the genetic puzzle of why men born with a BRCA2 mutation may develop aggressive localized cancers that resist treatment and become lethal for up to 50 per cent of patients within five years.
Canadian prostate cancer researchers have discovered the genetic fingerprint that explains why up to 30 per cent of men with potentially curable localized prostate cancer develop aggressive disease that spreads following radiotherapy or surgery.
Researchers at the University Health Network have found that when treating recurrent Clostridium difficile infection (RCDI), a single fecal transplantation delivered by enema is no more effective than the existing standard of care for RCDI, administration of oral vancomycin taper.
A team of researchers at the Krembil Research Institute has published a paper that is expected to change the way scientists think about vision recovery after retinal cell transplantation.
Scientists from the McEwen Centre for Regenerative Medicine, University Health Network, have developed the first functional pacemaker cells from human stem cells, paving the way for alternate, biological pacemaker therapy.
Results of the largest Canadian clinical trial to date comparing standard treatment for locally advanced squamous cell head and neck cancer with an experimental treatment, did not show the new treatment is superior.
Leukemia researchers at Princess Margaret Cancer Centre have developed a 17-gene signature derived from leukemia stem cells that can predict at diagnosis if patients with acute myeloid leukemia (AML) will respond to standard treatment.
The Princess Margaret Cancer Foundation is thrilled to be selected as one of Canada’s 10 Most Admired Corporate Cultures in the Broader Public Service category.
Researchers at the Krembil Neuroscience Centre’s (KNC) Canadian Concussion Centre (CCC) have identified symptom trends that may not only help predict how soon patients suffering from post-concussion syndrome (PCS) will recover, but also provide insight on how to treat those who experience persistent concussion symptoms.
Touchdowns scored during CFL post-season and Grey Cup raise money to support advanced heart failure patients
A team of researchers from the iDAPT labs at Toronto Rehabilitation Institute-University Health Network are dedicated to keeping Canadians safer this winter by offering evidence-based ratings on footwear that may reduce the risk of slips and falls on ice. The team has developed the first test of its kind in the world – the Maximum Achievable Angle (MAA) Testing Method – to validate slip resistant footwear on icy surfaces using real people in a simulated winter environment.
The Peter Munk Cardiac Centre has reached a major milestone within its Mechanical Circulatory Support Program - the largest mechanical heart program in Canada - implanting a 200th patient with a left ventricular assist device (LVAD).
The Princess Margaret Cancer Foundation is pleased to announce the launch of its annual Doves of Hope campaign. This year marks the 16th anniversary of the Doves of Hope Campaign.
A new method which doubles the usual time donor lungs can remain outside the body can benefit patients, staff and allow retrieval of donor lungs across greater geographical areas.
A signaling pathway has the potential to block a type of cancer in the cerebellum, suggests new research from a team at the Krembil Research Institute’s Donald K. Johnson Eye Institute.
The Princess Margaret Cancer Foundation is pleased to announce the Toronto Police Service has come on board to support breast cancer research at the Princess Margaret Cancer Centre.
Researchers from the University Health Network have described the genomic landscape of schwannomas in a paper published online today in Nature Genetics. Schwannomas are one of the most common posterior fossa brain tumours and the most common spinal tumour.
On Saturday October 1st, Scotiabank Road Hockey to Conquer Cancer faced off for its sixth hugely successful year. This year, 1786 players and their donors raised $2.5 million!
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right